Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T18:58:24.143Z.
Calculation as of: 2026-10-06T18:58:24.143Z.
Quote observation: 2026-10-06T18:51:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 73a05a26affbff61ca245286eab2f65fbc602d03c7bc752639a64992bef0efba
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$35.67M
Price/FCF Ratio
N/A
TTM Avg
507.99
3Y Avg
507.99
5Y Avg
507.99
Market Cap
$35.23M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$37.81M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | $36.28M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | N/A | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $36.41M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $35.67M | N/A | 507.99 | 507.99 | 507.99 |
| DocGo Inc. (DCGO)vs › | $35.54M | N/A | 2.50 | 3.99 | 20.14 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.23M | N/A | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $37.81M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $37.94M | N/A | 35.46 | 47.65 | 47.65 |
| Elutia Inc (ELUT)vs › | $34.48M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
